Policy update increases access for millions covered by Evernorth Health ServicesMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial ...
Study finds AI chatbot significantly improve symptoms for those suffering from major depressive disorder (MDD), generalized ...
Eating four or more servings of ultra-processed food daily increases the risk of depression by 10% in older adults and ...
Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...
They say when you're depressed, you need your friends more than ever. WebMD offers suggestions on how to maintain your ...
Depression is a major health issue around the world and one of the top causes of disability. Older adults are particularly at ...
Recognizing how persistent depressive disorder manifests and plays out in the lives of individuals is the first step in ...
Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, ...
Girls are twice as likely as boys to be diagnosed with depression, and researchers in London have now uncovered clues as to ...
Former Chicago police Det. Beth Svec was diagnosed with depression and anxiety in connection with retaliation and harassment ...
Depression affects about one in 20 adults, and while treatments like antidepressants and talk therapy help many people, they ...
The FDA has cleared Magstim Horizon 3.0 TMS Therapy System as an adjunct for the treatment of MDD in adolescent patients aged 15 to 21 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results